Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jan 13:13:1068449.
doi: 10.3389/fimmu.2022.1068449. eCollection 2022.

Protein post-translational modification in SARS-CoV-2 and host interaction

Affiliations
Review

Protein post-translational modification in SARS-CoV-2 and host interaction

Nana Cheng et al. Front Immunol. .

Abstract

SARS-CoV-2 can cause lung diseases, such as pneumonia and acute respiratory distress syndrome, and multi-system dysfunction. Post-translational modifications (PTMs) related to SARS-CoV-2 are conservative and pathogenic, and the common PTMs are glycosylation, phosphorylation, and acylation. The glycosylation of SARS-CoV-2 mainly occurs on spike (S) protein, which mediates the entry of the virus into cells through interaction with angiotensin-converting enzyme 2. SARS-CoV-2 utilizes glycans to cover its epitopes and evade the immune response through glycosylation of S protein. Phosphorylation of SARS-CoV-2 nucleocapsid (N) protein improves its selective binding to viral RNA and promotes viral replication and transcription, thereby increasing the load of the virus in the host. Succinylated N and membrane(M) proteins of SARS-CoV-2 synergistically affect virus particle assembly. N protein regulates its affinity for other proteins and the viral genome through acetylation. The acetylated envelope (E) protein of SARS-CoV-2 interacts with bromodomain-containing protein 2/4 to influence the host immune response. Both palmitoylation and myristoylation sites on S protein can affect the virus infectivity. Papain-like protease is a domain of NSP3 that dysregulates host inflammation by deubiquitination and impinges host IFN-I antiviral immune responses by deISGylation. Ubiquitination of ORF7a inhibits host IFN-α signaling by blocking STAT2 phosphorylation. The methylation of N protein can inhibit the formation of host stress granules and promote the binding of N protein to viral RNA, thereby promoting the production of virus particles. NSP3 macrodomain can reverse the ADP-ribosylation of host proteins, and inhibit the cascade immune response with IFN as the core, thereby promoting the intracellular replication of SARS-CoV-2. On the whole, PTMs have fundamental roles in virus entry, replication, particle assembly, and host immune response. Mutations in various SARS-CoV-2 variants, which lead to changes in PTMs at corresponding sites, cause different biological effects. In this paper, we mainly reviewed the effects of PTMs on SARS-CoV-2 and host cells, whose application is to inform the strategies for inhibiting viral infection and facilitating antiviral treatment and vaccine development for COVID-19.

Keywords: ADP-ribosylation; SARS-CoV-2; acylation; glycosylation; methylation; phosphorylation; ubiquitination.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Distribution of SARS-CoV-2 structural proteins post-translational modification sites in 2D and 3D structural models. (A) Distribution of SARS-CoV-2 spike protein post-translational modification sites. (B) Distribution of SARS-CoV-2 envelope protein post-translational modification sites. (C) Distribution of SARS-CoV-2 membrane protein post-translational modification sites. (D) Distribution of SARS-CoV-2 nucleocapsid protein post-translational modification sites. In 2D structural models, the post-translational modifications represented by the different colors are shown in the figure legends. NTD, N-terminal domain; CTD, C-terminal domain; RBD, receptor binding domain; SD1/2, subdomain 1/2; FP, fusion peptide; HR1/2, heptad repeat region 1/2; CH, central helix; CD, connector domain; TM, transmembrane region; Ext., external; Intra., intravirion. (Sites with * indicate that various protein post-translational modifications have occurred.) In 3D structural models, different colors were used to represent different post-translational modifications occurring at a certain site. Green: N-linked glycosylation; Orange: O-linked glycosylation; Cyan: phosphorylation; Magenta: succinylation; Pink: acetylation; Blue: methylation; Gray 90: succinylation and acetylation; Bluewhite: O-linked glycosylation and phosphorylation. Due to the limitations of the 3D model, some sites could not be marked. We used the open source software PyMOL for mapping, and data were obtained from the RCSB PDB database (https://www.rcsb.org/).
Figure 2
Figure 2
Mechanism of SARS-CoV-2 on PTMs of host proteins. ①Spike proteins recognize and bind to host cell surface receptors (ACE2, GAGS), TMPRSS2 and furin cleave the S1 and S2 subunits. ②Membrane fusion. ③The production of IFN: RIG-I and MAD5 recognize viral RNA and expose the CARD domain, through which RIG-I or MDA5 could interact with MAVS to activate the inhibitor of IκBϵ and TBK1, thereby phosphorylating IRF3 and phosphorylated IRF3 enters into the nucleus to activate IFN-I gene expression. ④The signaling process of IFN: Secreted IFN-α/β binds and activates JAK1 and TYK2, then they phosphorylate STAT1 and STAT2. Phosphorylated STAT1 and STAT2 can form heterodimers, which then bind to IRF9 to form a transcriptional complex IRF3 that translocates to the nucleus to induce the expression of ISG. ⑤NSP3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation of host proteins induced by IFN signaling. ⑥H3K27 can be methylated by EZH2 to form H3K27me3, then inhibits ACE2 expression in host cells. ⑦Highly expressed ACE2 receptors increase the risk of SARS-CoV-2 infection. ⑧NSP14 interacts with SIRT5 to reduce the level of protein succinylation in the host TCA cycle. The blue bars represent the metabolic enzymes in the TCA cycle.

Similar articles

Cited by

References

    1. Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of sars-Cov-2 entry into cells. Nat Rev Mol Cell Biol (2022) 23(1):3–20. doi: 10.1038/s41580-021-00418-x - DOI - PMC - PubMed
    1. Lamers MM, Haagmans BL. Sars-Cov-2 pathogenesis. Nat Rev Microbiol (2022) 20(5):270–84. doi: 10.1038/s41579-022-00713-0 - DOI - PubMed
    1. Shajahan A, Pepi L, Kumar B, Murray N, Azadi P. Site specific n- and O-glycosylation mapping of the spike proteins of sars-Cov-2 variants of concern. Res Sq (2022). doi: 10.21203/rs.3.rs-2188138/v1 - DOI - PMC - PubMed
    1. Shan Z, Han Q, Nie J, Cao X, Chen Z, Yin S, et al. . Negative regulation of interferon-induced transmembrane protein 3 by Set7-mediated lysine monomethylation. J Biol Chem (2013) 288(49):35093–103. doi: 10.1074/jbc.M113.511949 - DOI - PMC - PubMed
    1. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. . Sars-Cov-2 cell entry depends on Ace2 and Tmprss2 and is blocked by a clinically proven protease inhibitor. Cell (2020) 181(2):271–80.e8. doi: 10.1016/j.cell.2020.02.052 - DOI - PMC - PubMed

Publication types

Supplementary concepts

Grants and funding

This project was supported by International Joint Research Center for Pathogen and Infection Informatics, Jilin Province (grant number20210504004GH); young and middle-aged Science and Technology Innovation leading talents and team of Science and Technology Department of Jilin Province (grant number 20200301001RQ); Key Research and Development Program of Ministry of Science and Technology (grant number 2022YFF1203204) and Special Biosafety Research Program of Logistics Support Department of Military Commission(grant number 923070201202).